US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gain Therapeutics, Inc.

2.18

+0.13006.34%

Volume:929.48K

Turnover:2.01M

Market Cap:60.58M

PE:-2.44

High:2.25

Open:2.10

Low:2.01

Close:2.05

Loading ...

Overview Company News Filings

Promising Developments in Gain Therapeutics’ GT-02287 Drive Buy Rating

Gain Therapeutics Inc. to Present and Participate at The Citizens Life Sciences Conference

Gain Therapeutics to Participate at The Citizens Life Sciences Conference

BRIEF-Gain Therapeutics Announces Oral Poster Presentation

Gain Therapeutics Announces Oral Poster Presentation at Iaprd 2025 30TH World Congress on Parkinson’s Disease and Related Disorders

THOMSON REUTERS

Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Promising Developments in Gain Therapeutics’ Parkinson’s Treatment Justify Buy Rating

Gain Therapeutics Unveils New Parkinson’s Treatment Data

Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update

Gain Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Gain Therapeutics reports FY24 EPS (89c), consensus ($1.00)

Press Release: Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update

Gain Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Analysts Offer Insights on Healthcare Companies: 89bio (ETNB), Gain Therapeutics (GANX) and Boston Scientific (BSX)

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Gain Therapeutics doses first participant in Phase 1b trial of GT-02287

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

Calendar of U.S. Earnings Expected in the Week Ahead

Gain Therapeutics Announces Oral Presentation at AD/PD 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GANX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GANX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GANX\",,,,,undefined,":{"symbol":"GANX","market":"US","secType":"STK","nameCN":"Gain Therapeutics, Inc.","latestPrice":2.18,"timestamp":1746129600000,"preClose":2.05,"halted":0,"volume":929482,"delay":0,"floatShares":26450002,"shares":27786952,"eps":-0.892042,"marketStatus":"Pre-Mkt","change":0.13,"latestTime":"05-02 05:43:34 EDT","open":2.1,"high":2.25,"low":2.0101,"amount":2005492.654631,"amplitude":0.117024,"askPrice":3.48,"askSize":200,"bidPrice":1.88,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.892042,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746192600000},"marketStatusCode":1,"adr":0,"listingDate":1616040000000,"exchange":"NASDAQ","adjPreClose":2.18,"postHourTrading":{"tag":"盘后","latestPrice":2.18,"preClose":2.18,"latestTime":"17:38 EDT","volume":15,"amount":32.9357,"timestamp":1746135493870},"volumeRatio":2.6003176955339957,"impliedVol":0.8209,"impliedVolPercentile":0.4538},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GANX\",,,,,undefined,":{"symbol":"GANX","floatShares":26450002,"roa":"-82.80%","roe":"-204.95%","lyrEps":-0.892042,"volumeRatio":2.6003176955339957,"shares":27786952,"dividePrice":0,"high":2.25,"amplitude":0.117024,"preClose":2.05,"low":2.0101,"week52Low":0.89,"pbRate":"8.25","week52High":3.19,"institutionHeld":0,"latestPrice":2.18,"committee":-0.333333,"eps":-0.892042,"divideRate":0,"volume":929482,"delay":0,"ttmEps":-0.892042,"open":2.1,"prevYearClose":2.16,"prevWeekClose":1.895,"prevMonthClose":2.05,"prevQuarterClose":1.91,"fiveDayClose":1.88,"twentyDayClose":1.89,"sixtyDayClose":2.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GANX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532002303","title":"Promising Developments in Gain Therapeutics’ GT-02287 Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2532002303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532002303?lang=en_us&edition=fundamental","pubTime":"2025-05-01 23:35","pubTimestamp":1746113717,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Gain Therapeutics (GANX – Research Report), with a price...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-gain-therapeutics-gt-02287-drive-buy-rating-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-gain-therapeutics-gt-02287-drive-buy-rating-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GT","LENZ","GANX"],"gpt_icon":0},{"id":"2532075060","title":"Gain Therapeutics Inc. to Present and Participate at The Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532075060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532075060?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:30","pubTimestamp":1746099012,"startTime":"0","endTime":"0","summary":"Gain Therapeutics Inc., a clinical-stage biotechnology company, will participate in The Citizens Life Sciences Conference in New York City on May 7th-8th, 2025. The company's President and CEO, Gene Mack, is scheduled to present at the event on Thursday, May 8, 2025, at 12:00 p.m. EST.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gain Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on May 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL7dpYbT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4112","GANX","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","NDAQ"],"gpt_icon":0},{"id":"2532740080","title":"Gain Therapeutics to Participate at The Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532740080","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532740080?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:30","pubTimestamp":1746099000,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., May 01, 2025  -- Gain Therapeutics, Inc.  , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO of Gain, will present and participate in one-on-one meetings at The Citizens Life Sciences Conference, being held May 7th-8th in New York City, NY.Please contact your representative at Citizens if you would like to set up a one-on-one meeting with management.About Gain Therapeutics, Inc.Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being evaluated for the treatment of Parkinson’s disease with or without a GBA1 mutation in a Phase 1b clinical trial. GT-02287 has further potential in Gaucher’s disease, dementia with Lewy bodies, and Alzheimer’s disease. Gain has multiple undisclosed preclinical as","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-participate-citizens-life-113000327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LENZ","GANX","BK4007"],"gpt_icon":0},{"id":"2531605032","title":"BRIEF-Gain Therapeutics Announces Oral Poster Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2531605032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531605032?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:48","pubTimestamp":1746017310,"startTime":"0","endTime":"0","summary":"BRIEF-Gain Therapeutics Announces Oral Poster PresentationApril 30 (Reuters) - Gain Therapeutics Inc GANX.O:GAIN THERAPEUTICS ANNOUNCES ORAL POSTER PRESENTATION AT IAPRD 2025 30TH WORLD CONGRESS ON PA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA9LHVHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2531036537","title":"Gain Therapeutics Announces Oral Poster Presentation at Iaprd 2025 30TH World Congress on Parkinson’s Disease and Related Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036537?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:45","pubTimestamp":1746013500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA9LHVHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GANX"],"gpt_icon":0},{"id":"2531039959","title":"Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039959?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:45","pubTimestamp":1746013500,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., April 30, 2025  -- Gain Therapeutics, Inc.  , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced an oral poster presentation at the International Association of Parkinsonism and Related Disorders  30th World Congress on Parkinson's Disease and Related Disorders, being held May 7th-10th in New York City, NY.Details of the oral and poster presentation are as follows:. Presentation Title: GT-02287, A Clinical-stage Allosteric GCase Modulator For The Treatment Of Parkinson’s Disease, Protects Dopaminergic Neurons Against Mitochondrial Toxin MPP+. Presenter: Joanne Taylor, Ph.D., Senior Vice President of Research, Gain Therapeutics. Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with a >50% increase in glucocerebrosidase  activi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-announces-oral-poster-114500593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4119","BK4007","PD","GANX","LU1169589451.USD","BK4585","BK4588","BK4023","LU1169590202.USD","LENZ","BK4139","GT"],"gpt_icon":0},{"id":"2526610815","title":"Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526610815","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526610815?lang=en_us&edition=fundamental","pubTime":"2025-04-12 02:59","pubTimestamp":1744397965,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Gain Therapeutics, Inc.  stands against other top healthcare stocks to buy according to Billionaire David Einhorn.Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession. Major equity indexes have recorded their worst days in years, with the S&P 500 slipping back into correction territory. Amid the bloodbath, the focus is slowly turning to defensive sectors poised to shrug off the long-term effects of the trade war.“We have reached the ‘Fartcoin’ stage of the market cycle,” Einhorn wrote in an investor letter obtained by CNBC. “Other than trading and speculation, it serves no other obvious purpose and fulfills no need that is not served elsewhere.”“Within the equity market, we continue to recommend that investors own the healt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-ganx-top-healthcare-185925734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","OEX","TQQQ","QID","OEF","HCSG","SDS","GANX","BK4019","BK4550","BK4588","IVV","SH","SQQQ","USJW.SI","BK4137","BK4559","BK4585","NQmain","BK4504","BK4581","ESmain","BK4534","SPY","NVIW.SI","SSO","GLRE","MNQmain",".IXIC","QLD","BK4139","VOO",".SPX","TSYW.SI"],"gpt_icon":1},{"id":"2526184736","title":"Promising Developments in Gain Therapeutics’ Parkinson’s Treatment Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2526184736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526184736?lang=en_us&edition=fundamental","pubTime":"2025-04-12 00:35","pubTimestamp":1744389310,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Gain Therapeutics (GANX – Research Report), with a price...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-in-gain-therapeutics-parkinsons-treatment-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-in-gain-therapeutics-parkinsons-treatment-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","GANX"],"gpt_icon":0},{"id":"2526997528","title":"Gain Therapeutics Unveils New Parkinson’s Treatment Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2526997528","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526997528?lang=en_us&edition=fundamental","pubTime":"2025-04-11 05:18","pubTimestamp":1744319935,"startTime":"0","endTime":"0","summary":"Gain Therapeutics ( ($GANX) ) has issued an update. On April 10, 2025, Gain Therapeutics announced the presentation of new preclinical data and the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-unveils-new-parkinsons-treatment-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gain-therapeutics-unveils-new-parkinsons-treatment-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","GANX","BK4007","BK4139"],"gpt_icon":0},{"id":"2526517485","title":"Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2526517485","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526517485?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:00","pubTimestamp":1744282800,"startTime":"0","endTime":"0","summary":"GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson’s disease models. Phase 1b study ongoing to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of GT-02287 in people with Parkinson’s disease; biomarker analysis to be conducted in Q2 2025. Summary: In animal models of both GBA1 and idiopathic Parkinson’s disease, GT-02287 is able to rescue motor deficits and prevent the development of deficits in complex behaviors such as nesting. These effects persist even following withdrawal of the compound, suggesting a disease-modifying potential of GT-02287. The new preclinical data that were pres","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gain-therapeutics-presents-additional-preclinical-110000583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","GT","PD","BK4007","BK4218","LU1169590202.USD","PK","BK4119","BK4588","LENZ","GANX","BK4139","BK4023","CSF","LU1169589451.USD","BK4585"],"gpt_icon":0},{"id":"2522308173","title":"Gain Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522308173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522308173?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:49","pubTimestamp":1743079744,"startTime":"0","endTime":"0","summary":"Gain Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryGain Therapeutics Inc GANX.OQ reported a quarterly adjusted loss of 11 cents per share for the quarter ended D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA13Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX"],"gpt_icon":0},{"id":"2522831379","title":"Gain Therapeutics reports FY24 EPS (89c), consensus ($1.00)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522831379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522831379?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:17","pubTimestamp":1743074237,"startTime":"0","endTime":"0","summary":"“2024 was a year of significant progress for Gain, as we made important advancements related to both the scientific understanding and clinical deve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-reports-fy24-eps-89c-consensus-1-00?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-reports-fy24-eps-89c-consensus-1-00?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","GANX"],"gpt_icon":0},{"id":"2522756913","title":"Press Release: Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522756913","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522756913?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:01","pubTimestamp":1743073260,"startTime":"0","endTime":"0","summary":"Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update. First Analysis from Phase 1b Study of GT-02287 in Parkinson's Disease Expected in Q2 2025. BETHESDA, Md., March 27, 2025  -- Gain Therapeutics, Inc.  , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided a corporate update.-- First participant dosed in the Phase 1b trial of GT-02287 in Parkinson's. disease. First analysis is anticipated at the end of the second quarter. -- Presented new clinical data from a Phase 1 study of GT-02287 in healthy. volunteers that demonstrated favorable safety and tolerability, plasma. exposure in the projected therapeutic range, CNS exposure, and target. engagement with a statistically significant >50% increase in. clinically relevant doses during the Mi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","LU1169589451.USD","BK4119","03160","BK4023","BK4555","BK4585","BK4588","BK4604","GANX","BK4139","GT","LU1169590202.USD","PD","LENZ","BK4099"],"gpt_icon":0},{"id":"2521898122","title":"Gain Therapeutics Inc  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521898122","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521898122?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:59","pubTimestamp":1742561947,"startTime":"0","endTime":"0","summary":"Gain Therapeutics Inc  expected to post a loss of18cents a share - Earnings Preview Gain Therapeutics Inc GANX.OQ GANX.O is expected to show no change in quarterly revenue when it reports  results on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q414O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX"],"gpt_icon":0},{"id":"2520243757","title":"Analysts Offer Insights on Healthcare Companies: 89bio (ETNB), Gain Therapeutics (GANX) and Boston Scientific (BSX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520243757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520243757?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:50","pubTimestamp":1742467809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on 89bio (ETNB – Research Report), Gain Therapeutics (GANX – Researc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-89bio-etnb-gain-therapeutics-ganx-and-boston-scientific-bsx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-89bio-etnb-gain-therapeutics-ganx-and-boston-scientific-bsx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU2362541513.USD","BK4137","LU1791710400.SGD","LU2491050154.USD","BK4588","LU1153585028.USD","LU0353189763.USD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU0011850046.USD","BK4139","HCSG","BK4082","IE0009355771.USD","LU2087625088.SGD","BK4581","LU0528227936.USD","LU0238689110.USD","LU0266013472.USD","LU1989764664.SGD","LU0345769631.USD","ETNB","LU2506952170.USD","LU0251132253.USD","LU0187121727.USD","LU2362541273.HKD","LU0950375773.USD","LU0882574055.USD","LU1291159041.SGD","LU1718418525.SGD","LU1983299246.USD","BK4585","GANX","LU1023059063.AUD","LU1804176565.USD","LU0048584097.USD","LU0353189680.USD","LU2324357040.USD","LU2242649171.HKD","BSX","LU1791710582.SGD","LU0345769128.USD","LU2506952097.USD","LU2265009873.SGD","LU0267386448.USD","LU0077335932.USD","LU2491050071.SGD","LU1989772923.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2520499155","title":"Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520499155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520499155?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:04","pubTimestamp":1742209440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GANX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 07:04 ET (11:04 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX","LENZ"],"gpt_icon":0},{"id":"2519808424","title":"Gain Therapeutics doses first participant in Phase 1b trial of GT-02287","url":"https://stock-news.laohu8.com/highlight/detail?id=2519808424","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519808424?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:50","pubTimestamp":1741953040,"startTime":"0","endTime":"0","summary":"Gain Therapeutics (GANX) announced the dosing of the first participant with Parkinson’s disease in its Phase 1b clinical trial of GT-02287, the Com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-doses-first-participant-in-phase-1b-trial-of-gt-02287?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-doses-first-participant-in-phase-1b-trial-of-gt-02287?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4119","GT","BK4588","BK4139","GANX","BK4585"],"gpt_icon":0},{"id":"2519995808","title":"Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2519995808","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519995808?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:45","pubTimestamp":1741952700,"startTime":"0","endTime":"0","summary":"Interim Analysis Expected End of 2Q 2025BETHESDA, Md., March  14, 2025  (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company le","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042895/0/en/Gain-Therapeutics-Doses-First-Participant-in-Phase-1b-Clinical-Trial-of-GT-02287-in-Parkinson-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GT","LENZ","LU1169590202.USD","BK4023","GANX","LU1169589451.USD","PD","BK4139","BK4119","BK4588"],"gpt_icon":0},{"id":"2519876572","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876572?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:00","pubTimestamp":1741946400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIS","SPRY","ERAS","LXEO","DRI","AUTL","GOGO","LAR","MGNX","PRSO","LE","TYRA","NKTX","ACN","RANI","INSE","OSS","STNE","ABSI","JILL","DTIL","RLYB","FDX","AEVA","GANX","LVTX","INKT","AMPX","PL","FDS","IFRX","HROW","LPRO","KOPN","MBRX","ANRO","DTI","LQDA","CAL","HTHT","IDN","CAPR","HYPR","CNTX","TME","NRXP","MRC"],"gpt_icon":1},{"id":"2517154760","title":"Gain Therapeutics Announces Oral Presentation at AD/PD 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154760","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154760?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:55","pubTimestamp":1741265700,"startTime":"0","endTime":"0","summary":"BETHESDA, Md., March  06, 2025  (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038110/0/en/Gain-Therapeutics-Announces-Oral-Presentation-at-AD-PD-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GT","LU1169590202.USD","BK4119","PD","BK4585","LENZ","BK4023","GANX","BK4588","LU1169589451.USD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GANX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"GANX","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-11-14","symbol":"GANX","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-08-08","symbol":"GANX","fiscalQuarterEnding":"2024/06","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2024-05-14","symbol":"GANX","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-03-26","symbol":"GANX","fiscalQuarterEnding":"2023/12","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711425600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GANX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GANX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GANX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GANX","date":"2025-05-01","current":-2.790785,"percent":0.535141,"low":-50.040751,"twenty":-5.258317,"median":-2.872692,"eighty":-2.177798,"high":-1.058647,"avg":-5.880927,"sd":8.457127,"marketCap":56963251},"quantilePoints":[{"date":"2021-03-19","current":-38.639061,"twenty":-38.005634,"median":-37.055493,"eighty":-36.105352,"marketCap":138238273},{"date":"2021-03-26","current":-42.819681,"twenty":-41.432475,"median":-39.494188,"eighty":-38.512375,"marketCap":153195201},{"date":"2021-04-01","current":-48.773897,"twenty":-46.430216,"median":-41.806197,"eighty":-38.639061,"marketCap":174497492},{"date":"2021-04-09","current":-44.276563,"twenty":-46.873615,"median":-44.308234,"eighty":-39.494188,"marketCap":158407463},{"date":"2021-04-16","current":-45.923474,"twenty":-46.430216,"median":-44.339906,"eighty":-39.937587,"marketCap":164299587},{"date":"2021-04-23","current":-38.322347,"twenty":-46.30353,"median":-44.260728,"eighty":-39.494188,"marketCap":137105172},{"date":"2021-04-30","current":-38.258688,"twenty":-45.923474,"median":-42.756338,"eighty":-38.639061,"marketCap":136877419},{"date":"2021-05-07","current":-33.25493,"twenty":-45.305882,"median":-40.95107,"eighty":-38.322347,"marketCap":118975563},{"date":"2021-05-14","current":-20.96541,"twenty":-44.65662,"median":-39.937587,"eighty":-35.471925,"marketCap":114132780},{"date":"2021-05-21","current":-23.05977,"twenty":-44.414334,"median":-38.939939,"eighty":-23.05977,"marketCap":125534182},{"date":"2021-05-28","current":-23.103402,"twenty":-44.339906,"median":-38.639061,"eighty":-22.928872,"marketCap":125771711},{"date":"2021-06-04","current":-23.212484,"twenty":-44.339906,"median":-38.322347,"eighty":-22.849069,"marketCap":126365534},{"date":"2021-06-11","current":-22.165304,"twenty":-44.289232,"median":-37.372048,"eighty":-22.470731,"marketCap":120664833},{"date":"2021-06-18","current":-19.809149,"twenty":-44.251226,"median":-35.471925,"eighty":-22.108582,"marketCap":107838256},{"date":"2021-06-25","current":-22.645261,"twenty":-43.104723,"median":-34.046714,"eighty":-21.471547,"marketCap":123277654},{"date":"2021-07-02","current":-21.83806,"twenty":-42.769007,"median":-23.539727,"eighty":-21.750795,"marketCap":118883364},{"date":"2021-07-09","current":-21.598082,"twenty":-42.186253,"median":-23.212484,"eighty":-21.471547,"marketCap":117576954},{"date":"2021-07-16","current":-20.638167,"twenty":-41.806197,"median":-23.081586,"eighty":-21.384282,"marketCap":112351311},{"date":"2021-07-23","current":-19.63462,"twenty":-40.780045,"median":-22.928872,"eighty":-21.030859,"marketCap":106888140},{"date":"2021-07-30","current":-17.452995,"twenty":-40.095943,"median":-22.740271,"eighty":-20.585808,"marketCap":95011680},{"date":"2021-08-06","current":-17.452995,"twenty":-40.000929,"median":-22.470731,"eighty":-20.267291,"marketCap":95011680},{"date":"2021-08-13","current":-11.234424,"twenty":-39.671548,"median":-22.350741,"eighty":-19.976349,"marketCap":95011680},{"date":"2021-08-20","current":-11.192295,"twenty":-39.247151,"median":-22.165304,"eighty":-19.617167,"marketCap":94655386},{"date":"2021-08-27","current":-10.925477,"twenty":-38.911435,"median":-22.056223,"eighty":-18.107483,"marketCap":92398858},{"date":"2021-09-03","current":-10.897391,"twenty":-38.702404,"median":-21.83806,"eighty":-17.452995,"marketCap":92161329},{"date":"2021-09-10","current":-12.680856,"twenty":-38.639061,"median":-21.772611,"eighty":-17.452995,"marketCap":107244433},{"date":"2021-09-17","current":-11.150166,"twenty":-38.575718,"median":-21.543541,"eighty":-12.939248,"marketCap":94299092},{"date":"2021-09-24","current":-10.433971,"twenty":-38.417361,"median":-21.401735,"eighty":-11.225998,"marketCap":88242097},{"date":"2021-10-01","current":-10.377799,"twenty":-38.322347,"median":-21.343486,"eighty":-11.183869,"marketCap":87767039},{"date":"2021-10-08","current":-9.87225,"twenty":-38.296883,"median":-20.96541,"eighty":-11.093994,"marketCap":83491513},{"date":"2021-10-15","current":-9.745863,"twenty":-37.549376,"median":-20.659983,"eighty":-10.970415,"marketCap":82422632},{"date":"2021-10-22","current":-9.689691,"twenty":-36.270043,"median":-20.507269,"eighty":-10.908625,"marketCap":81947574},{"date":"2021-10-29","current":-9.773949,"twenty":-35.756967,"median":-20.256383,"eighty":-10.852453,"marketCap":82660161},{"date":"2021-11-05","current":-10.93952,"twenty":-35.218554,"median":-19.983679,"eighty":-10.766286,"marketCap":92517623},{"date":"2021-11-12","current":-7.951084,"twenty":-34.838498,"median":-19.887252,"eighty":-10.706406,"marketCap":98007879},{"date":"2021-11-19","current":-7.97036,"twenty":-34.205071,"median":-19.63462,"eighty":-10.462057,"marketCap":98245474},{"date":"2021-11-26","current":-7.565577,"twenty":-31.316253,"median":-19.547355,"eighty":-10.422737,"marketCap":93255982},{"date":"2021-12-03","current":-6.283766,"twenty":-23.557181,"median":-18.107483,"eighty":-10.068852,"marketCap":77455924},{"date":"2021-12-10","current":-5.782607,"twenty":-23.478642,"median":-17.562076,"eighty":-9.925613,"marketCap":71278458},{"date":"2021-12-17","current":-5.68623,"twenty":-23.229937,"median":-17.452995,"eighty":-9.83293,"marketCap":70090483},{"date":"2021-12-23","current":-5.488658,"twenty":-23.212484,"median":-17.452995,"eighty":-9.745863,"marketCap":67655136},{"date":"2021-12-31","current":-5.233259,"twenty":-23.190667,"median":-17.234833,"eighty":-9.619475,"marketCap":64507004},{"date":"2022-01-07","current":-5.117607,"twenty":-23.103402,"median":-12.673834,"eighty":-9.380744,"marketCap":63081435},{"date":"2022-01-14","current":-4.510433,"twenty":-23.05977,"median":-11.234424,"eighty":-8.876301,"marketCap":55597197},{"date":"2022-01-21","current":-4.211665,"twenty":-23.024864,"median":-11.220381,"eighty":-7.966505,"marketCap":51914476},{"date":"2022-01-28","current":-3.787607,"twenty":-22.946325,"median":-11.185274,"eighty":-7.552084,"marketCap":46687389},{"date":"2022-02-04","current":-4.471883,"twenty":-22.876514,"median":-11.150166,"eighty":-6.729027,"marketCap":55122007},{"date":"2022-02-11","current":-3.999636,"twenty":-22.806003,"median":-11.058886,"eighty":-5.936809,"marketCap":49300933},{"date":"2022-02-18","current":-3.633405,"twenty":-22.709445,"median":-11.023778,"eighty":-5.67852,"marketCap":44786631},{"date":"2022-02-25","current":-3.23826,"twenty":-22.662714,"median":-10.953563,"eighty":-5.503114,"marketCap":39915936},{"date":"2022-03-04","current":-3.469564,"twenty":-22.540543,"median":-10.943031,"eighty":-5.422158,"marketCap":42767074},{"date":"2022-03-11","current":-3.286448,"twenty":-22.470731,"median":-10.897391,"eighty":-5.273737,"marketCap":40509923},{"date":"2022-03-18","current":-3.662318,"twenty":-22.418372,"median":-10.883348,"eighty":-5.16965,"marketCap":45143023},{"date":"2022-03-25","current":-3.593086,"twenty":-22.344197,"median":-10.841219,"eighty":-4.874737,"marketCap":49910145},{"date":"2022-04-01","current":-3.652971,"twenty":-22.278748,"median":-10.735896,"eighty":-4.506578,"marketCap":50741981},{"date":"2022-04-08","current":-3.610196,"twenty":-22.20021,"median":-10.700789,"eighty":-4.441042,"marketCap":50147812},{"date":"2022-04-14","current":-3.285107,"twenty":-22.165304,"median":-10.504186,"eighty":-4.344665,"marketCap":45632133},{"date":"2022-04-22","current":-2.883024,"twenty":-22.156578,"median":-10.458547,"eighty":-4.2001,"marketCap":40046950},{"date":"2022-04-29","current":-2.925799,"twenty":-22.073676,"median":-10.419928,"eighty":-4.051679,"marketCap":40641118},{"date":"2022-05-06","current":-2.934354,"twenty":-21.934052,"median":-10.075874,"eighty":-3.993854,"marketCap":40759952},{"date":"2022-05-13","current":-2.284176,"twenty":-21.86424,"median":-10.054809,"eighty":-3.882689,"marketCap":31728592},{"date":"2022-05-20","current":-2.229222,"twenty":-21.829334,"median":-9.963529,"eighty":-3.764313,"marketCap":32798095},{"date":"2022-05-27","current":-2.334221,"twenty":-21.798791,"median":-9.87225,"eighty":-3.662318,"marketCap":34342933},{"date":"2022-06-03","current":-2.826911,"twenty":-21.768248,"median":-9.830121,"eighty":-3.637318,"marketCap":41591788},{"date":"2022-06-10","current":-2.915757,"twenty":-21.720252,"median":-9.759906,"eighty":-3.577687,"marketCap":42898958},{"date":"2022-06-17","current":-2.939988,"twenty":-21.576266,"median":-9.703734,"eighty":-3.516424,"marketCap":43255459},{"date":"2022-06-24","current":-3.166141,"twenty":-21.489,"median":-9.619475,"eighty":-3.469564,"marketCap":46582802},{"date":"2022-07-01","current":-2.802681,"twenty":-21.445368,"median":-9.486066,"eighty":-3.387767,"marketCap":41235286},{"date":"2022-07-08","current":-3.06518,"twenty":-21.410462,"median":-9.338615,"eighty":-3.353912,"marketCap":45097381},{"date":"2022-07-15","current":-3.238833,"twenty":-21.366829,"median":-8.905214,"eighty":-3.305907,"marketCap":47652305},{"date":"2022-07-22","current":-3.392294,"twenty":-21.352169,"median":-8.346229,"eighty":-3.283396,"marketCap":49910145},{"date":"2022-07-29","current":-3.214602,"twenty":-21.339167,"median":-7.951084,"eighty":-3.269708,"marketCap":47295804},{"date":"2022-08-05","current":-3.238833,"twenty":-21.126851,"median":-7.666773,"eighty":-3.238718,"marketCap":47652305},{"date":"2022-08-12","current":-3.036412,"twenty":-20.987226,"median":-7.343911,"eighty":-3.217833,"marketCap":49315977},{"date":"2022-08-19","current":-2.677896,"twenty":-20.947957,"median":-6.645179,"eighty":-3.203421,"marketCap":43493126},{"date":"2022-08-26","current":-2.633996,"twenty":-20.734158,"median":-6.197027,"eighty":-3.16291,"marketCap":42780124},{"date":"2022-09-02","current":-2.670579,"twenty":-20.646893,"median":-5.777788,"eighty":-3.140295,"marketCap":43374293},{"date":"2022-09-09","current":-2.838862,"twenty":-20.559628,"median":-5.691049,"eighty":-3.098295,"marketCap":46107467},{"date":"2022-09-16","current":-2.773013,"twenty":-20.507269,"median":-5.512752,"eighty":-3.060757,"marketCap":45037964},{"date":"2022-09-23","current":-2.436446,"twenty":-20.45491,"median":-5.495886,"eighty":-3.036412,"marketCap":39571615},{"date":"2022-09-30","current":-2.38523,"twenty":-20.354555,"median":-5.445288,"eighty":-3.001607,"marketCap":38739779},{"date":"2022-10-07","current":-2.377913,"twenty":-20.245474,"median":-5.334454,"eighty":-2.954271,"marketCap":38620946},{"date":"2022-10-14","current":-2.304747,"twenty":-20.123304,"median":-5.262172,"eighty":-2.937734,"marketCap":37432609},{"date":"2022-10-21","current":-2.268163,"twenty":-20.018585,"median":-5.218803,"eighty":-2.923218,"marketCap":36838440},{"date":"2022-10-28","current":-2.436446,"twenty":-19.983679,"median":-5.107969,"eighty":-2.904662,"marketCap":39571615},{"date":"2022-11-04","current":-2.23158,"twenty":-19.972684,"median":-4.862208,"eighty":-2.887257,"marketCap":36244272},{"date":"2022-11-11","current":-2.363977,"twenty":-19.871631,"median":-4.683911,"eighty":-2.847642,"marketCap":38145611},{"date":"2022-11-18","current":-2.271553,"twenty":-19.704432,"median":-4.491158,"eighty":-2.799594,"marketCap":36654248},{"date":"2022-11-25","current":-2.282968,"twenty":-19.63462,"median":-4.471883,"eighty":-2.747199,"marketCap":36838440},{"date":"2022-12-02","current":-2.38607,"twenty":-19.617167,"median":-4.385143,"eighty":-2.673506,"marketCap":38502112},{"date":"2022-12-09","current":-2.297697,"twenty":-19.573534,"median":-4.303223,"eighty":-2.657297,"marketCap":37076108},{"date":"2022-12-16","current":-2.194595,"twenty":-19.451363,"median":-4.211665,"eighty":-2.615297,"marketCap":35412436},{"date":"2022-12-23","current":-2.31979,"twenty":-18.827419,"median":-4.134564,"eighty":-2.563756,"marketCap":37432609},{"date":"2022-12-30","current":-2.305061,"twenty":-18.107483,"median":-4.057462,"eighty":-2.511076,"marketCap":37194941},{"date":"2023-01-06","current":-2.38607,"twenty":-18.107483,"median":-4.009274,"eighty":-2.45108,"marketCap":38502112},{"date":"2023-01-13","current":-2.85754,"twenty":-17.88932,"median":-3.989999,"eighty":-2.45108,"marketCap":46109844},{"date":"2023-01-20","current":-2.813206,"twenty":-17.627525,"median":-3.901065,"eighty":-2.474493,"marketCap":45394465},{"date":"2023-01-27","current":-2.997316,"twenty":-17.474811,"median":-3.865235,"eighty":-2.491936,"marketCap":48365307},{"date":"2023-02-03","current":-2.908943,"twenty":-17.452995,"median":-3.772741,"eighty":-2.506657,"marketCap":46939303},{"date":"2023-02-10","current":-3.019409,"twenty":-17.452995,"median":-3.7346,"eighty":-2.515467,"marketCap":48721808},{"date":"2023-02-17","current":-3.034138,"twenty":-17.452995,"median":-3.662318,"eighty":-2.522783,"marketCap":48959476},{"date":"2023-02-24","current":-3.093053,"twenty":-17.452995,"median":-3.652971,"eighty":-2.542969,"marketCap":49910145},{"date":"2023-03-03","current":-2.901579,"twenty":-17.452995,"median":-3.601641,"eighty":-2.558678,"marketCap":46820469},{"date":"2023-03-10","current":-2.70274,"twenty":-17.322098,"median":-3.575976,"eighty":-2.56522,"marketCap":43611960},{"date":"2023-03-17","current":-3.402359,"twenty":-14.890034,"median":-3.537028,"eighty":-2.572536,"marketCap":54901160},{"date":"2023-03-24","current":-3.31018,"twenty":-12.939248,"median":-3.556303,"eighty":-2.584243,"marketCap":58228503},{"date":"2023-03-31","current":-3.256136,"twenty":-12.67243,"median":-3.507537,"eighty":-2.601339,"marketCap":57277833},{"date":"2023-04-06","current":-3.161559,"twenty":-12.363483,"median":-3.484273,"eighty":-2.615297,"marketCap":55614162},{"date":"2023-04-14","current":-3.222359,"twenty":-11.773676,"median":-3.422611,"eighty":-2.625327,"marketCap":56683665},{"date":"2023-04-21","current":-3.377734,"twenty":-11.231615,"median":-3.396322,"eighty":-2.628142,"marketCap":59416840},{"date":"2023-04-28","current":-3.343957,"twenty":-11.220381,"median":-3.394308,"eighty":-2.638656,"marketCap":58822671},{"date":"2023-05-05","current":-3.559408,"twenty":-11.220381,"median":-3.399341,"eighty":-2.657297,"marketCap":62612613},{"date":"2023-05-12","current":-3.559408,"twenty":-11.192295,"median":-3.469564,"eighty":-2.657297,"marketCap":62612613},{"date":"2023-05-19","current":-2.987047,"twenty":-11.192295,"median":-3.399341,"eighty":-2.660595,"marketCap":58114231},{"date":"2023-05-26","current":-2.921345,"twenty":-11.178252,"median":-3.392294,"eighty":-2.665374,"marketCap":56835980},{"date":"2023-06-01","current":-2.921345,"twenty":-11.172635,"median":-3.392294,"eighty":-2.665592,"marketCap":56835980},{"date":"2023-06-09","current":-3.041748,"twenty":-11.158592,"median":-3.387767,"eighty":-2.667782,"marketCap":59178460},{"date":"2023-06-16","current":-3.086107,"twenty":-11.138932,"median":-3.367601,"eighty":-2.672042,"marketCap":60041480},{"date":"2023-06-23","current":-2.946693,"twenty":-11.093994,"median":-3.353912,"eighty":-2.677896,"marketCap":57329133},{"date":"2023-06-30","current":-2.851638,"twenty":-11.093994,"median":-3.353912,"eighty":-2.692802,"marketCap":55479807},{"date":"2023-07-07","current":-2.813617,"twenty":-11.065908,"median":-3.343957,"eighty":-2.706414,"marketCap":54740076},{"date":"2023-07-14","current":-2.851638,"twenty":-11.023778,"median":-3.343832,"eighty":-2.711925,"marketCap":55479807},{"date":"2023-07-21","current":-2.788269,"twenty":-11.023778,"median":-3.327679,"eighty":-2.71548,"marketCap":54246922},{"date":"2023-07-28","current":-2.414387,"twenty":-11.023778,"median":-3.315049,"eighty":-2.677896,"marketCap":46972903},{"date":"2023-08-04","current":-2.433398,"twenty":-10.995692,"median":-3.296669,"eighty":-2.660595,"marketCap":47342768},{"date":"2023-08-11","current":-2.249626,"twenty":-10.953563,"median":-3.284133,"eighty":-2.629844,"marketCap":43767403},{"date":"2023-08-18","current":-2.141714,"twenty":-10.953563,"median":-3.276552,"eighty":-2.590096,"marketCap":47241849},{"date":"2023-08-25","current":-2.066869,"twenty":-10.946542,"median":-3.256136,"eighty":-2.555451,"marketCap":45590924},{"date":"2023-09-01","current":-1.905665,"twenty":-10.93952,"median":-3.255071,"eighty":-2.522116,"marketCap":42035086},{"date":"2023-09-08","current":-2.101413,"twenty":-10.928286,"median":-3.242333,"eighty":-2.506657,"marketCap":46352890},{"date":"2023-09-15","current":-2.118685,"twenty":-10.903008,"median":-3.238546,"eighty":-2.45108,"marketCap":46733872},{"date":"2023-09-22","current":-1.859607,"twenty":-10.897391,"median":-3.237064,"eighty":-2.443763,"marketCap":41019133},{"date":"2023-09-29","current":-1.836577,"twenty":-10.891774,"median":-3.233315,"eighty":-2.434617,"marketCap":40511156},{"date":"2023-10-06","current":-1.853849,"twenty":-10.883348,"median":-3.228622,"eighty":-2.422892,"marketCap":40892138},{"date":"2023-10-13","current":-1.905665,"twenty":-10.883348,"median":-3.216622,"eighty":-2.408163,"marketCap":42035086},{"date":"2023-10-19","current":-1.819305,"twenty":-10.877731,"median":-3.214602,"eighty":-2.407413,"marketCap":40130173},{"date":"2023-10-27","current":-1.689766,"twenty":-10.872114,"median":-3.211725,"eighty":-2.400612,"marketCap":37272803},{"date":"2023-11-03","current":-1.571742,"twenty":-10.846836,"median":-3.206525,"eighty":-2.394988,"marketCap":34669422},{"date":"2023-11-10","current":-1.537198,"twenty":-10.809313,"median":-3.201846,"eighty":-2.38607,"marketCap":33907456},{"date":"2023-11-17","current":-1.577567,"twenty":-10.754602,"median":-3.188379,"eighty":-2.377913,"marketCap":35050404},{"date":"2023-11-24","current":-1.470271,"twenty":-10.734492,"median":-3.181826,"eighty":-2.377294,"marketCap":32666513},{"date":"2023-12-01","current":-1.456658,"twenty":-10.720449,"median":-3.170608,"eighty":-2.363863,"marketCap":32364046},{"date":"2023-12-08","current":-1.715317,"twenty":-10.706406,"median":-3.161559,"eighty":-2.334519,"marketCap":38110932},{"date":"2023-12-15","current":-1.72893,"twenty":-10.675512,"median":-3.1529,"eighty":-2.326697,"marketCap":38413400},{"date":"2023-12-22","current":-1.701703,"twenty":-10.565976,"median":-3.149476,"eighty":-2.316598,"marketCap":37808465},{"date":"2023-12-29","current":-2.001203,"twenty":-10.49576,"median":-3.142591,"eighty":-2.30481,"marketCap":44462754},{"date":"2024-01-05","current":-2.653959,"twenty":-10.470483,"median":-3.14191,"eighty":-2.304998,"marketCap":58965699},{"date":"2024-01-12","current":-2.478972,"twenty":-10.462057,"median":-3.131855,"eighty":-2.310953,"marketCap":55077851},{"date":"2024-01-19","current":-2.449808,"twenty":-10.457844,"median":-3.127002,"eighty":-2.316598,"marketCap":54429876},{"date":"2024-01-26","current":-2.584693,"twenty":-10.442397,"median":-3.117791,"eighty":-2.319626,"marketCap":57426759},{"date":"2024-02-02","current":-2.748743,"twenty":-10.425545,"median":-3.101526,"eighty":-2.323934,"marketCap":61071617},{"date":"2024-02-09","current":-3.52889,"twenty":-10.394651,"median":-3.114271,"eighty":-2.326697,"marketCap":78404941},{"date":"2024-02-16","current":-3.499726,"twenty":-10.200857,"median":-3.12332,"eighty":-2.326697,"marketCap":77756966},{"date":"2024-02-23","current":-3.237246,"twenty":-10.077278,"median":-3.129876,"eighty":-2.329623,"marketCap":71925193},{"date":"2024-03-01","current":-3.273702,"twenty":-10.068852,"median":-3.141293,"eighty":-2.334096,"marketCap":72735162},{"date":"2024-03-08","current":-3.353904,"twenty":-10.063235,"median":-3.142591,"eighty":-2.33434,"marketCap":74517092},{"date":"2024-03-15","current":-3.120589,"twenty":-10.049192,"median":-3.149476,"eighty":-2.334519,"marketCap":69333295},{"date":"2024-03-22","current":-3.186209,"twenty":-10.035149,"median":-3.146375,"eighty":-2.337465,"marketCap":70791238},{"date":"2024-03-28","current":-2.71694,"twenty":-10.001446,"median":-3.14191,"eighty":-2.342324,"marketCap":60499514},{"date":"2024-04-05","current":-2.60768,"twenty":-9.897527,"median":-3.133833,"eighty":-2.344999,"marketCap":58066558},{"date":"2024-04-12","current":-2.447431,"twenty":-9.883484,"median":-3.128878,"eighty":-2.351656,"marketCap":54498222},{"date":"2024-04-19","current":-2.294467,"twenty":-9.866633,"median":-3.122511,"eighty":-2.334519,"marketCap":51092083},{"date":"2024-04-26","current":-2.236195,"twenty":-9.841355,"median":-3.116031,"eighty":-2.32816,"marketCap":49794506},{"date":"2024-05-03","current":-2.375312,"twenty":-9.824504,"median":-3.101526,"eighty":-2.334055,"marketCap":52892298},{"date":"2024-05-10","current":-2.059144,"twenty":-9.796418,"median":-3.099567,"eighty":-2.326697,"marketCap":45852026},{"date":"2024-05-17","current":-2.296581,"twenty":-9.768332,"median":-3.093281,"eighty":-2.319462,"marketCap":48559823},{"date":"2024-05-24","current":-2.091682,"twenty":-9.745863,"median":-3.086107,"eighty":-2.310851,"marketCap":44227348},{"date":"2024-05-31","current":-2.142907,"twenty":-9.745863,"median":-3.086075,"eighty":-2.304747,"marketCap":45310467},{"date":"2024-06-07","current":-1.99777,"twenty":-9.703734,"median":-3.084057,"eighty":-2.301286,"marketCap":42241630},{"date":"2024-06-14","current":-1.613583,"twenty":-9.6925,"median":-3.07977,"eighty":-2.296158,"marketCap":34118240},{"date":"2024-06-21","current":-1.109872,"twenty":-9.647561,"median":-3.073433,"eighty":-2.287738,"marketCap":23467572},{"date":"2024-06-28","current":-1.067185,"twenty":-9.619475,"median":-3.06518,"eighty":-2.282968,"marketCap":22564973},{"date":"2024-07-05","current":-1.380767,"twenty":-9.585772,"median":-3.054123,"eighty":-2.281358,"marketCap":29195490},{"date":"2024-07-12","current":-1.618831,"twenty":-9.50994,"median":-3.043368,"eighty":-2.269333,"marketCap":34229195},{"date":"2024-07-15","current":-1.642637,"twenty":-9.493088,"median":-3.041748,"eighty":-2.268239,"marketCap":34732565},{"date":"2024-08-02","current":-1.261736,"twenty":-9.490279,"median":-3.041748,"eighty":-2.268178,"marketCap":26678637},{"date":"2024-08-09","current":-1.151036,"twenty":-9.459385,"median":-3.036412,"eighty":-2.251312,"marketCap":24337964},{"date":"2024-08-16","current":-1.454136,"twenty":-9.363892,"median":-3.035004,"eighty":-2.246146,"marketCap":31408615},{"date":"2024-08-23","current":-1.548714,"twenty":-9.276826,"median":-3.026774,"eighty":-2.240189,"marketCap":33451452},{"date":"2024-08-30","current":-1.26498,"twenty":-9.139591,"median":-3.019409,"eighty":-2.232503,"marketCap":27322942},{"date":"2024-09-06","current":-1.282713,"twenty":-8.905214,"median":-3.012045,"eighty":-2.224263,"marketCap":27705974},{"date":"2024-09-13","current":-1.73787,"twenty":-8.876301,"median":-3.002793,"eighty":-2.209324,"marketCap":37537126},{"date":"2024-09-20","current":-1.767425,"twenty":-8.442606,"median":-2.996921,"eighty":-2.187231,"marketCap":38175512},{"date":"2024-09-27","current":-2.181204,"twenty":-8.249852,"median":-2.987047,"eighty":-2.173047,"marketCap":47112923},{"date":"2024-10-04","current":-2.033426,"twenty":-7.97036,"median":-2.960339,"eighty":-2.17264,"marketCap":43920991},{"date":"2024-10-11","current":-2.328982,"twenty":-7.951084,"median":-2.951464,"eighty":-2.17264,"marketCap":50304856},{"date":"2024-10-18","current":-3.274761,"twenty":-7.873983,"median":-2.949765,"eighty":-2.172683,"marketCap":70733224},{"date":"2024-10-25","current":-3.168361,"twenty":-7.767968,"median":-2.960185,"eighty":-2.172683,"marketCap":68435032},{"date":"2024-10-31","current":-2.577249,"twenty":-7.606055,"median":-2.960494,"eighty":-2.172974,"marketCap":55667302},{"date":"2024-11-08","current":-2.63636,"twenty":-7.511606,"median":-2.953803,"eighty":-2.176255,"marketCap":56944075},{"date":"2024-11-15","current":-2.062981,"twenty":-7.374751,"median":-2.946693,"eighty":-2.176255,"marketCap":44559377},{"date":"2024-11-22","current":-1.93605,"twenty":-7.050925,"median":-2.939988,"eighty":-2.172674,"marketCap":41367445},{"date":"2024-11-29","current":-2.309018,"twenty":-6.862027,"median":-2.934187,"eighty":-2.172585,"marketCap":49336626},{"date":"2024-12-06","current":-2.122807,"twenty":-6.61723,"median":-2.926662,"eighty":-2.172486,"marketCap":45357866},{"date":"2024-12-13","current":-2.07315,"twenty":-6.372433,"median":-2.923672,"eighty":-2.164769,"marketCap":44296863},{"date":"2024-12-20","current":-1.94901,"twenty":-6.231723,"median":-2.921345,"eighty":-2.145744,"marketCap":41644356},{"date":"2024-12-27","current":-1.986252,"twenty":-6.10836,"median":-2.919346,"eighty":-2.141714,"marketCap":42440108},{"date":"2025-01-03","current":-2.880065,"twenty":-5.936809,"median":-2.915757,"eighty":-2.141953,"marketCap":61538157},{"date":"2025-01-10","current":-3.029034,"twenty":-5.782607,"median":-2.916308,"eighty":-2.142907,"marketCap":64721165},{"date":"2025-01-17","current":-2.942135,"twenty":-5.772969,"median":-2.915757,"eighty":-2.142907,"marketCap":62864411},{"date":"2025-01-24","current":-2.768338,"twenty":-5.711288,"median":-2.909045,"eighty":-2.146689,"marketCap":59150901},{"date":"2025-01-31","current":-2.731096,"twenty":-5.688158,"median":-2.908671,"eighty":-2.148289,"marketCap":58355149},{"date":"2025-02-07","current":-3.277315,"twenty":-5.655389,"median":-2.908176,"eighty":-2.151009,"marketCap":70026179},{"date":"2025-02-14","current":-3.178003,"twenty":-5.539737,"median":-2.908943,"eighty":-2.152913,"marketCap":67904174},{"date":"2025-02-21","current":-2.904893,"twenty":-5.506969,"median":-2.909147,"eighty":-2.164769,"marketCap":62068659},{"date":"2025-02-28","current":-2.358674,"twenty":-5.503114,"median":-2.908807,"eighty":-2.172486,"marketCap":50397629},{"date":"2025-03-07","current":-2.234533,"twenty":-5.49444,"median":-2.906324,"eighty":-2.172502,"marketCap":47745122},{"date":"2025-03-14","current":-2.731096,"twenty":-5.479984,"median":-2.901579,"eighty":-2.172585,"marketCap":58355149},{"date":"2025-03-21","current":-2.842823,"twenty":-5.456853,"median":-2.901579,"eighty":-2.172666,"marketCap":60742405},{"date":"2025-03-28","current":-2.569713,"twenty":-5.410592,"median":-2.900856,"eighty":-2.172683,"marketCap":54906890},{"date":"2025-04-04","current":-2.436832,"twenty":-5.387462,"median":-2.891579,"eighty":-2.172901,"marketCap":49738644},{"date":"2025-04-11","current":-2.150947,"twenty":-5.323853,"median":-2.88966,"eighty":-2.172683,"marketCap":43903384},{"date":"2025-04-17","current":-2.368764,"twenty":-5.281447,"median":-2.882893,"eighty":-2.172829,"marketCap":48349296},{"date":"2025-04-25","current":-2.559354,"twenty":-5.273737,"median":-2.880065,"eighty":-2.174651,"marketCap":52239469},{"date":"2025-05-01","current":-2.790785,"twenty":-5.258317,"median":-2.872692,"eighty":-2.177798,"marketCap":56963251}],"updateTime":1746179014556}}}